China's online healthcare untouched by internet antitrust push | Healthcare Asia Magazine
, China

China's online healthcare untouched by internet antitrust push

Shares of online healthcare firms soared despite new antitrust laws on internet companies.

China's crackdown on internet companies, including Alibaba Group, is unlikely to affect the sector’s burgeoning healthcare businesses, and could even transform the medical sector into a key battleground for e-commerce and tech companies, according to S&P Global.

The report noted that even after a sharp selloff since 23 December due to China's new antitrust laws and action against Alibaba and its affiliates, the shares of key Chinese online healthcare companies even soared in 2020.

Further, the market cap of JD Health more than doubled to $62.67b from $29b since it went public, whilst that of Ping An Healthcare and Technology surged 66%. Tencent-backed WeDoctor reportedly has plans to go public in 2021.

China ramped up scrutiny of its internet companies, with Alibaba and its affiliates hit hard by the regulatory action. After the suspension of a dual-listing by Alibaba's fintech arm, Ant Group, regulators opened an investigation into Alibaba for alleged anti-competitive practices.

But analysts believe that the heavier oversight is unlikely to creep into the online healthcare market, which has benefited from favorable new rules in recent months.

China's Drug Administration Law, which came into force in December 2019, permits drug developers, manufacturers and sellers, and third-party e-commerce platforms to sell prescription medicines online.

The rules were then followed by draft regulations in November 2020 outlining more explicit procedures for online consultation, sales of prescription drugs, and price harmonization for online and offline drugs and medical services.

Online is expected to account for 6% of total pharmacy sales in 2020, a jump from 2.2% in 2018 but still a long way from the 31%, or $27.34b (RMB177b), projected for 2028, according to a report from Deloitte. About 48% of online pharmacy sales in 2028 is expected to come from prescription drugs.

Analysts said the pandemic has already stretched the country's healthcare system, and the government will see e-commerce giants as a pivotal resource to deliver on its aim of promoting online consultations and internet hospitals as part of its five-year development plan.
 

Pemindaian AI terkini meningkatkan diagnosa di Shin Kong Wu Ho-Su Memorial Hospital

Rumah sakit di Taiwan ini menggunakan teknologi endoskop yang dibantu AI untuk mendeteksi polip dan kamera resolusi tinggi untuk telemedis.

KFSHRC Saudi bertumpu pada inovasi untuk mentransformasi layanan kesehatan

Rumah sakit ini mempercepat adopsi teknologi baru untuk memposisikan dirinya sebagai pemimpin global di bidang kedokteran.

Angkor Hospital merencanakan pusat trauma untuk anak-anak

Fasilitas ini akan memiliki ICU, ruang gawat darurat, ruang operasi, dan bangsal bedah.

Bali International Hospital dan HK Asia Medical mendirikan pusat jantung baru

Fasilitas ini akan menawarkan diagnostik, operasi invasif minimal, dan perawatan pasca operasi.

Pasar pencitraan medis Indonesia diproyeksikan tumbuh 6,12% CAGR hingga 2030

Salah satu pendorong utama adalah peningkatan inisiatif yang dipimpin pemerintah.

Rumah Sakit Pusat Kamboja beralih ke adopsi teknologi untuk meningkatkan layanan jantung

Salah satu teknologi kunci mereka adalah mesin ECMO untuk mendukung hidup yang berkepanjangan dalam kondisi kritis.

Ekspor farmasi Indonesia diperkirakan tumbuh 7,7% CAGR hingga 2028

Berkat upaya pemerintah dan aturan investasi baru untuk meningkatkan produksi domestik.

Jepang dan Indonesia tandatangani MoU untuk pelatihan perawat dan pekerja perawatan

Kemitraan ini bertujuan membimbing tenaga kesehatan Indonesia agar memenuhi standar tenaga kerja profesional Jepang.

Pusat gigi nasional Singapura berada di garda terdepan layanan gigi digital

Teknologi pemindaian intraoralnya menggantikan metode pencetakan gigi tradisional.

Inovasi medis global dan solusi berbasis AI menjadi sorotan

Medical Taiwan 2024 menghadirkan 280 peserta dari 10 negara dan mendorong integrasi teknologi dalam layanan kesehatan.